Microdosing psilocybin mushrooms has been shown to have mental health and mood benefits after … [+]
Denver Mail via Getty Images
a new study published in Nature: scientific reports has seen significant benefits for mood and mental health after one month of microdosing psilocybin mushrooms.
Mushroom microdosers saw greater improvements in DASS domains than Depression, AnxietyY Stress. The study indicates that they found no difference in these outcomes between genders, but did find that the cognitive efficacy of microdosing was greater in people under the age of 55.
The study analyzed 1133 people over the course of two years. All subjects were over 18 years old, could read English, and had access to an iPhone iOS device where participants recorded their results. scientific reports is a peer-reviewed, open access scientific journal published online by Nature Portfolio.
The study was conducted by a team of experts in the fields of psychology and mycology: Joseph M. RootmanDepartment of Psychology, University of British Columbia, Kelowna, BC, Canada; Maggie Kiragaan employee of Quantified Citizen Technologies. pamela kryskowmember of the Numinus Wellness clinical advisory board, co-founder of MycoMedica Life Sciences and member of the scientific and medical advisory board; Kalin Harvey; Paul Stametswho founded Fungi Perfecti, LLC; Eesmyal Santos-Brault; Kim PC Kuyper; Y Zach WalshMember of the Advisory Council of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada and MycoMedica Life Sciences.
“This study is an extension of our earlier manuscript published in the same journal, and we have more publications in the pipeline that are based on this same study,” says Joseph Rootman, a researcher at the Department of Psychology at the University of British Columbia. He says the team plans to continue this line of research and expand on these findings in the future. “Our team has also been hard at work developing the next version of the study that will be used to generate findings related to psychedelic microdosing for years to come.”
There isn’t a specific type of fungus, or strain, that the study used because it was “observational in nature,” says Rootman. The researchers did not provide any psilocybin mushrooms to the participants, but observed and recorded the participants’ experiences as they engaged in their own “practice microdosing.”
“In this early version of the study, we didn’t ask participants specifically what strain of fungus they were using. Although we collect data about a practice called piled up where psilocybin mushrooms are combined with other non-psychedelics like Lion’s Mane mushrooms or chocolate,” says Rootman. “Our first study noted that about half of the microdosers in our sample were stacked with a wide variety of substances, while our most recent study extended these findings by noting associated improvements in psychomotor ability among the stacked microdosers relative to their non-stacking peers or They don’t microdose.”
So how much exactly is considered a microdose of psilocybin? The team looked for precedents. “Based on previous psilocybin microdose studies, we classified participants’ psilocybin dose responses into low, medium, and high microdoses corresponding to ≤ 0.1 grams of dried mushrooms, 0.1 to 0.3 grams of dried mushrooms , ≥ 0.3 grams of dried mushrooms, respectively,” says Rootman. . Most of the participants landed somewhere in the middle range of 0.1 to 0.3 grams of psilocybin. “We found that about 10% of our microdosing sample in this study reported high doses, 72.6% reported medium doses, and 16.8% reported low doses.”
These findings join the ranks of many legitimate peer-reviewed academic studies that regard psilocybin as a hopeful treatment for depression. the Journal of Psychopharmacology published a follow-up earlier this year to this widely publicized Johns Hopkins Medicine study which found that psilocybin can continue to help people with depression for up to a year later.
.
